Cardinal Health Inc. (CAH) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 26	$2.42	$2.6	+7.4%	—	$63.7B	—
Q3 26	$2.79	$3.17	+13.6%	—	$60.9B	—
Q2 26	$1.61	$1.87	+16.1%	—	$65.6B	—
Q4 25	$2.03	$2.08	+2.5%	—	$60.2B	—
Q3 25	$2.15	$2.35	+9.3%	—	$54.9B	—
Q2 25	$1.76	$1.93	+9.7%	—	$55.3B	—
Q1 25	$1.62	$1.88	+16.0%	—	$52.3B	—
Q4 24	$1.73	$1.84	+6.4%	—	$59.7B	—
Q3 24	$1.95	$2.08	+6.7%	—	$54.9B	—
Q2 24	$1.6	$1.82	+13.7%	—	$57.4B	—
Q1 24	$1.41	$1.73	+22.7%	—	$54.6B	—
Q4 23	$1.48	$1.55	+4.7%	—	$53.5B	—
Q3 23	$1.49	$1.74	+16.8%	—	$50.5B	—
Q2 23	$1.14	$1.32	+15.8%	—	$51.5B	—
Q1 23	$0.97	$1.2	+23.7%	—	$49.6B	—
Q4 22	$1.18	$1.05	-11.0%	—	$47.1B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$7.27	—	—	$254.2B	—
FY25	—	$6.48	—	—	$222.6B	—
FY24	—	$3.48	—	—	$226.8B	—
FY23	—	$1.27	—	—	$205B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$130B	$136.8B	$145.5B	$152.9B	$162.5B	$181.3B	$205B	$226.8B	$222.6B	$254.2B
YoY change	+6.94%	+5.26%	+6.38%	+5.08%	+6.24%	+11.6%	+13%	+10.7%	-1.87%	+14.2%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	130B	136.8B	145.5B	152.9B	162.5B	181.3B	205B	226.8B	222.6B	254.2B
Cost of revenue	123.4B	129.6B	138.7B	146.1B	155.7B	174.8B	198.1B	219.4B	214.4B	244.5B
Gross profit	6.5B	7.2B	6.8B	6.9B	6.8B	6.5B	6.9B	7.4B	8.2B	9.8B
Gross margin	5.03%	5.25%	4.7%	4.49%	4.17%	3.58%	3.35%	3.27%	3.67%	3.84%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	3.8B	4.6B	4.5B	4.6B	4.5B	4.5B	4.8B	5B	5.4B	6.1B
Operating expenses	3.8B	4.6B	4.5B	4.6B	4.5B	4.5B	4.8B	5B	5.4B	6.1B
Operating income	2.2B	1.9B	1.7B	1.8B	1.8B	1.6B	1.8B	2.1B	2.3B	3.2B
Operating margin	1.72%	1.37%	1.19%	1.16%	1.1%	0.91%	0.87%	0.94%	1.04%	1.25%
Non-operating income, net	-117M	-1.8B	312M	-5.3B	-1.3B	-2.3B	-1B	-878M	-6M	-651M
Pretax income	1.9B	-228M	1.8B	-3.8B	323M	-784M	663M	1.2B	2.1B	2.2B
Income tax	630M	-487M	386M	-79M	-289M	153M	332M	348M	532M	469M
Net income	1.3B	259M	1.4B	-3.7B	612M	-937M	331M	853M	1.6B	1.7B
Net margin	1%	0.19%	0.94%	-2.41%	0.38%	-0.52%	0.16%	0.38%	0.7%	0.67%
EBITDA	3B	2.9B	2.7B	2.7B	2.6B	2.3B	2.5B	2.8B	3.2B	4.2B
EPS	4.06	0.82	4.55	-12.6	2.09	-3.35	1.27	3.48	6.48	7.27
Diluted EPS	4.03	0.81	4.53	-12.6	2.08	-3.35	1.26	3.45	6.45	7.23

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	54.6B	57.4B	54.9B	59.7B	52.3B	55.3B	54.9B	60.2B	64B	65.6B	60.9B	63.7B
Cost of revenue	52.9B	55.6B	53B	57.9B	50.4B	53.3B	52.8B	58B	61.7B	63.2B	58.4B	61.1B
Gross profit	1.7B	1.9B	1.9B	1.9B	1.9B	1.9B	2.1B	2.2B	2.3B	2.4B	2.5B	2.6B
Gross margin	3.19%	3.23%	3.55%	3.1%	3.64%	3.51%	3.87%	3.66%	3.62%	3.65%	4.1%	4.02%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	1.2B	1.3B	1.3B	1.2B	1.3B	1.3B	1.3B	1.5B	1.5B	1.5B	1.5B	1.6B
Operating expenses	1.2B	1.3B	1.3B	1.2B	1.3B	1.3B	1.3B	1.5B	1.5B	1.5B	1.5B	1.6B
Operating income	493M	523M	585M	538M	551M	530M	656M	585M	754M	763M	842M	814M
Operating margin	0.9%	0.91%	1.07%	0.9%	1.05%	0.96%	1.2%	0.97%	1.18%	1.16%	1.38%	1.28%
Non-operating income, net	-526M	-8M	-211M	-146M	22M	16M	83M	-127M	-76M	-45M	-349M	-181M
Pretax income	-44M	512M	341M	396M	541M	511M	665M	384M	598M	630M	392M	554M
Income tax	-33M	143M	82M	162M	124M	110M	157M	141M	144M	159M	12M	154M
Net income	-11M	369M	259M	234M	417M	401M	508M	243M	454M	471M	380M	400M
Net margin	-0.02%	0.64%	0.47%	0.39%	0.8%	0.73%	0.93%	0.4%	0.71%	0.72%	0.62%	0.63%
EBITDA	664M	708M	769M	708M	738M	719M	872M	824M	997M	1B	1.1B	1.1B
EPS	-0.05	1.5	1.06	0.96	1.7	1.65	2.11	1.01	1.89	1.98	1.69	1.7
Diluted EPS	-0.05	1.5	1.05	0.96	1.7	1.65	2.1	1	1.88	1.97	1.69	1.7

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	24.7B	15.3B	14.1B	15.3B	16.7B	14.6B	24.7B	24.1B	40.5B	56.1B	51B
Enterprise value	28.2B	22.5B	19.6B	19.3B	19.5B	15.2B	25.3B	24B	45.1B	60.1B	56.5B
Shares outstanding	317M	313M	300M	293M	292M	279M	261M	245M	241M	236M	236M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	19.1	59	10.4	—	27.2	—	74.6	28.2	25.8	32.9	30.6
P/S	0.19	0.11	0.1	0.1	0.1	0.08	0.12	0.11	0.18	0.22	0.2
P/B	3.62	2.52	2.23	8.53	9.29	-20.7	-8.35	-7.5	-15.4	-20.6	-18.9
EV/EBITDA	9.52	7.81	7.22	7.18	7.43	6.55	10.2	8.44	14.3	14.4	13.3
EV/Sales	0.22	0.16	0.13	0.13	0.12	0.08	0.12	0.11	0.2	0.24	0.22
Earnings yield	5.24%	1.69%	9.66%	—	3.67%	—	1.34%	3.54%	3.88%	3.04%	3.27%
FCF yield	3.23%	15.6%	16.9%	10.4%	12.2%	19.1%	9.57%	13.5%	4.57%	8.07%	9.32%
PEG	—	—	—	—	—	—	—	—	—	—	0.45

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	5.03%	5.25%	4.7%	4.49%	4.17%	3.58%	3.35%	3.27%	3.67%	3.84%	4.02%
Operating margin	1.72%	1.37%	1.19%	1.16%	1.1%	0.91%	0.87%	0.94%	1.04%	1.25%	1.33%
Net margin	1%	0.19%	0.94%	-2.41%	0.38%	-0.52%	0.16%	0.38%	0.7%	0.67%	0.67%
ROE	19%	4.27%	21.6%	-206.1%	34.1%	132.7%	-11.2%	-26.6%	-59.6%	-62.6%	-62.9%
ROA	3.23%	0.65%	3.33%	-9.06%	1.38%	-2.14%	0.76%	1.89%	2.95%	2.98%	3.72%
ROIC	14.6%	14.1%	11.4%	30.6%	38.8%	-1.5K%	-38.3%	-46.5%	85.9%	190.5%	190.5%
Return on tangible assets	5.96%	1.67%	7.87%	-20.3%	2.52%	-3.27%	1.06%	2.65%	5.45%	5.68%	5.68%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	1.34	1.07	1.07	1.1	1.12	1.08	1	0.98	0.94	0.88	0.88
Quick ratio	0.8	0.53	0.54	0.54	0.6	0.57	0.52	0.56	0.5	0.49	0.49
Debt / equity	1.52	1.49	1.27	3.78	3.48	-7.53	-1.59	-1.59	-3.24	-3.26	-0.04
Debt / assets	0.26	0.23	0.2	0.17	0.14	0.12	0.11	0.11	0.16	0.16	0.16
Net debt / EBITDA	1.19	2.51	2.02	1.49	1.08	0.26	0.25	-0.01	1.48	0.97	0.97
Interest coverage	10.6	0.31	6.96	-14.8	2.79	-4.33	8.89	24.5	10.8	7.25	7.25
Effective tax rate	32.7%	0%	22%	0%	0%	0%	50.1%	29%	25.3%	21.6%	21.6%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	410	437.1	485.1	521.9	556.4	649.9	785.4	925.8	923.6	1.1K	1.1K
EPS (basic)	4.06	0.82	4.55	-12.6	2.09	-3.35	1.27	3.48	6.48	7.27	7.27
EPS (diluted)	4.03	0.81	4.53	-12.6	2.08	-3.35	1.26	3.45	6.45	7.23	7.22
Book value per share	21.5	19.4	21.1	6.12	6.14	-2.53	-11.3	-13.1	-10.9	-11.5	-12.4
FCF per share	2.51	7.62	7.98	5.41	6.95	9.99	9.05	13.3	7.68	19.2	19.3
Cash per share	21.7	5.63	8.44	9.46	11.7	16.9	15.6	21	16.1	20.6	20.9
Capex per share	1.21	1.53	1.45	1.27	1.37	1.28	1.8	2.04	—	—	—

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	0.3%	0.35%	0.3%	0.24%	0.25%	0.2%	0.23%	0.22%	—	—	—
Capex / operating cash flow	23.7%	56%	14.9%	-9.01%	22%	44.7%	18.5%	14.2%	—	—	—
Payout ratio	44.6%	224.3%	42.3%	-15.4%	93.6%	-59.7%	158.6%	58.5%	31.5%	28.8%	28.3%
Dividend yield	2.34%	3.8%	4.08%	3.72%	3.44%	3.83%	2.13%	2.07%	1.22%	0.88%	0.94%

Yield

0.94%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.516

ex-dividend Jul 1, 2026

Payout ratio

28%

of earnings

Dividend growth

1 year

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jul 1, 2026	$0.516
Apr 1, 2026	$0.511
Jan 2, 2026	$0.511

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 26	$2.42	$2.6	+7.4%	—	$63.7B	—
Q3 26	$2.79	$3.17	+13.6%	—	$60.9B	—
Q2 26	$1.61	$1.87	+16.1%	—	$65.6B	—
Q4 25	$2.03	$2.08	+2.5%	—	$60.2B	—
Q3 25	$2.15	$2.35	+9.3%	—	$54.9B	—
Q2 25	$1.76	$1.93	+9.7%	—	$55.3B	—
Q1 25	$1.62	$1.88	+16.0%	—	$52.3B	—
Q4 24	$1.73	$1.84	+6.4%	—	$59.7B	—
Q3 24	$1.95	$2.08	+6.7%	—	$54.9B	—
Q2 24	$1.6	$1.82	+13.7%	—	$57.4B	—
Q1 24	$1.41	$1.73	+22.7%	—	$54.6B	—
Q4 23	$1.48	$1.55	+4.7%	—	$53.5B	—
Q3 23	$1.49	$1.74	+16.8%	—	$50.5B	—
Q2 23	$1.14	$1.32	+15.8%	—	$51.5B	—
Q1 23	$0.97	$1.2	+23.7%	—	$49.6B	—
Q4 22	$1.18	$1.05	-11.0%	—	$47.1B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$7.27	—	—	$254.2B	—
FY25	—	$6.48	—	—	$222.6B	—
FY24	—	$3.48	—	—	$226.8B	—
FY23	—	$1.27	—	—	$205B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$130B	$136.8B	$145.5B	$152.9B	$162.5B	$181.3B	$205B	$226.8B	$222.6B	$254.2B
YoY change	+6.94%	+5.26%	+6.38%	+5.08%	+6.24%	+11.6%	+13%	+10.7%	-1.87%	+14.2%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	130B	136.8B	145.5B	152.9B	162.5B	181.3B	205B	226.8B	222.6B	254.2B
Cost of revenue	123.4B	129.6B	138.7B	146.1B	155.7B	174.8B	198.1B	219.4B	214.4B	244.5B
Gross profit	6.5B	7.2B	6.8B	6.9B	6.8B	6.5B	6.9B	7.4B	8.2B	9.8B
Gross margin	5.03%	5.25%	4.7%	4.49%	4.17%	3.58%	3.35%	3.27%	3.67%	3.84%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	3.8B	4.6B	4.5B	4.6B	4.5B	4.5B	4.8B	5B	5.4B	6.1B
Operating expenses	3.8B	4.6B	4.5B	4.6B	4.5B	4.5B	4.8B	5B	5.4B	6.1B
Operating income	2.2B	1.9B	1.7B	1.8B	1.8B	1.6B	1.8B	2.1B	2.3B	3.2B
Operating margin	1.72%	1.37%	1.19%	1.16%	1.1%	0.91%	0.87%	0.94%	1.04%	1.25%
Non-operating income, net	-117M	-1.8B	312M	-5.3B	-1.3B	-2.3B	-1B	-878M	-6M	-651M
Pretax income	1.9B	-228M	1.8B	-3.8B	323M	-784M	663M	1.2B	2.1B	2.2B
Income tax	630M	-487M	386M	-79M	-289M	153M	332M	348M	532M	469M
Net income	1.3B	259M	1.4B	-3.7B	612M	-937M	331M	853M	1.6B	1.7B
Net margin	1%	0.19%	0.94%	-2.41%	0.38%	-0.52%	0.16%	0.38%	0.7%	0.67%
EBITDA	3B	2.9B	2.7B	2.7B	2.6B	2.3B	2.5B	2.8B	3.2B	4.2B
EPS	4.06	0.82	4.55	-12.6	2.09	-3.35	1.27	3.48	6.48	7.27
Diluted EPS	4.03	0.81	4.53	-12.6	2.08	-3.35	1.26	3.45	6.45	7.23

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	54.6B	57.4B	54.9B	59.7B	52.3B	55.3B	54.9B	60.2B	64B	65.6B	60.9B	63.7B
Cost of revenue	52.9B	55.6B	53B	57.9B	50.4B	53.3B	52.8B	58B	61.7B	63.2B	58.4B	61.1B
Gross profit	1.7B	1.9B	1.9B	1.9B	1.9B	1.9B	2.1B	2.2B	2.3B	2.4B	2.5B	2.6B
Gross margin	3.19%	3.23%	3.55%	3.1%	3.64%	3.51%	3.87%	3.66%	3.62%	3.65%	4.1%	4.02%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	1.2B	1.3B	1.3B	1.2B	1.3B	1.3B	1.3B	1.5B	1.5B	1.5B	1.5B	1.6B
Operating expenses	1.2B	1.3B	1.3B	1.2B	1.3B	1.3B	1.3B	1.5B	1.5B	1.5B	1.5B	1.6B
Operating income	493M	523M	585M	538M	551M	530M	656M	585M	754M	763M	842M	814M
Operating margin	0.9%	0.91%	1.07%	0.9%	1.05%	0.96%	1.2%	0.97%	1.18%	1.16%	1.38%	1.28%
Non-operating income, net	-526M	-8M	-211M	-146M	22M	16M	83M	-127M	-76M	-45M	-349M	-181M
Pretax income	-44M	512M	341M	396M	541M	511M	665M	384M	598M	630M	392M	554M
Income tax	-33M	143M	82M	162M	124M	110M	157M	141M	144M	159M	12M	154M
Net income	-11M	369M	259M	234M	417M	401M	508M	243M	454M	471M	380M	400M
Net margin	-0.02%	0.64%	0.47%	0.39%	0.8%	0.73%	0.93%	0.4%	0.71%	0.72%	0.62%	0.63%
EBITDA	664M	708M	769M	708M	738M	719M	872M	824M	997M	1B	1.1B	1.1B
EPS	-0.05	1.5	1.06	0.96	1.7	1.65	2.11	1.01	1.89	1.98	1.69	1.7
Diluted EPS	-0.05	1.5	1.05	0.96	1.7	1.65	2.1	1	1.88	1.97	1.69	1.7

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	24.7B	15.3B	14.1B	15.3B	16.7B	14.6B	24.7B	24.1B	40.5B	56.1B	51B
Enterprise value	28.2B	22.5B	19.6B	19.3B	19.5B	15.2B	25.3B	24B	45.1B	60.1B	56.5B
Shares outstanding	317M	313M	300M	293M	292M	279M	261M	245M	241M	236M	236M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	19.1	59	10.4	—	27.2	—	74.6	28.2	25.8	32.9	30.6
P/S	0.19	0.11	0.1	0.1	0.1	0.08	0.12	0.11	0.18	0.22	0.2
P/B	3.62	2.52	2.23	8.53	9.29	-20.7	-8.35	-7.5	-15.4	-20.6	-18.9
EV/EBITDA	9.52	7.81	7.22	7.18	7.43	6.55	10.2	8.44	14.3	14.4	13.3
EV/Sales	0.22	0.16	0.13	0.13	0.12	0.08	0.12	0.11	0.2	0.24	0.22
Earnings yield	5.24%	1.69%	9.66%	—	3.67%	—	1.34%	3.54%	3.88%	3.04%	3.27%
FCF yield	3.23%	15.6%	16.9%	10.4%	12.2%	19.1%	9.57%	13.5%	4.57%	8.07%	9.32%
PEG	—	—	—	—	—	—	—	—	—	—	0.45

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	5.03%	5.25%	4.7%	4.49%	4.17%	3.58%	3.35%	3.27%	3.67%	3.84%	4.02%
Operating margin	1.72%	1.37%	1.19%	1.16%	1.1%	0.91%	0.87%	0.94%	1.04%	1.25%	1.33%
Net margin	1%	0.19%	0.94%	-2.41%	0.38%	-0.52%	0.16%	0.38%	0.7%	0.67%	0.67%
ROE	19%	4.27%	21.6%	-206.1%	34.1%	132.7%	-11.2%	-26.6%	-59.6%	-62.6%	-62.9%
ROA	3.23%	0.65%	3.33%	-9.06%	1.38%	-2.14%	0.76%	1.89%	2.95%	2.98%	3.72%
ROIC	14.6%	14.1%	11.4%	30.6%	38.8%	-1.5K%	-38.3%	-46.5%	85.9%	190.5%	190.5%
Return on tangible assets	5.96%	1.67%	7.87%	-20.3%	2.52%	-3.27%	1.06%	2.65%	5.45%	5.68%	5.68%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	1.34	1.07	1.07	1.1	1.12	1.08	1	0.98	0.94	0.88	0.88
Quick ratio	0.8	0.53	0.54	0.54	0.6	0.57	0.52	0.56	0.5	0.49	0.49
Debt / equity	1.52	1.49	1.27	3.78	3.48	-7.53	-1.59	-1.59	-3.24	-3.26	-0.04
Debt / assets	0.26	0.23	0.2	0.17	0.14	0.12	0.11	0.11	0.16	0.16	0.16
Net debt / EBITDA	1.19	2.51	2.02	1.49	1.08	0.26	0.25	-0.01	1.48	0.97	0.97
Interest coverage	10.6	0.31	6.96	-14.8	2.79	-4.33	8.89	24.5	10.8	7.25	7.25
Effective tax rate	32.7%	0%	22%	0%	0%	0%	50.1%	29%	25.3%	21.6%	21.6%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	410	437.1	485.1	521.9	556.4	649.9	785.4	925.8	923.6	1.1K	1.1K
EPS (basic)	4.06	0.82	4.55	-12.6	2.09	-3.35	1.27	3.48	6.48	7.27	7.27
EPS (diluted)	4.03	0.81	4.53	-12.6	2.08	-3.35	1.26	3.45	6.45	7.23	7.22
Book value per share	21.5	19.4	21.1	6.12	6.14	-2.53	-11.3	-13.1	-10.9	-11.5	-12.4
FCF per share	2.51	7.62	7.98	5.41	6.95	9.99	9.05	13.3	7.68	19.2	19.3
Cash per share	21.7	5.63	8.44	9.46	11.7	16.9	15.6	21	16.1	20.6	20.9
Capex per share	1.21	1.53	1.45	1.27	1.37	1.28	1.8	2.04	—	—	—

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	0.3%	0.35%	0.3%	0.24%	0.25%	0.2%	0.23%	0.22%	—	—	—
Capex / operating cash flow	23.7%	56%	14.9%	-9.01%	22%	44.7%	18.5%	14.2%	—	—	—
Payout ratio	44.6%	224.3%	42.3%	-15.4%	93.6%	-59.7%	158.6%	58.5%	31.5%	28.8%	28.3%
Dividend yield	2.34%	3.8%	4.08%	3.72%	3.44%	3.83%	2.13%	2.07%	1.22%	0.88%	0.94%

Yield

0.94%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.516

ex-dividend Jul 1, 2026

Payout ratio

28%

of earnings

Dividend growth

1 year

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jul 1, 2026	$0.516
Apr 1, 2026	$0.511
Jan 2, 2026	$0.511

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	$54.6B	$57.4B	$54.9B	$59.7B	$52.3B	$55.3B	$54.9B	$60.2B	$64B	$65.6B	$60.9B	$63.7B
YoY change	+10.2%	+11.6%	+8.76%	+11.7%	-4.34%	-3.79%	-0.06%	+0.76%	+22.4%	+18.8%	+11%	+5.84%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	6.9B	1.8B	2.5B	2.8B	3.4B	4.7B	4.1B	5.1B	3.9B	4.9B
Receivables	8B	7.8B	8.4B	8.3B	9.1B	10.6B	11.1B	12.1B	13.2B	13.8B
Inventory	11.3B	12.3B	12.8B	13.2B	14.6B	15.6B	16.1B	15B	16.8B	17.3B
Total current assets	28.3B	24.6B	25.7B	25.9B	31B	32.9B	33.7B	34.9B	36.4B	38.8B
Property, plant & equipment	3.5B	4.6B	4.3B	4.6B	4.1B	4.1B	4.2B	2.5B	2.9B	3B
Goodwill & intangibles	18.4B	24.5B	23.6B	22.6B	20.2B	15.3B	12.2B	12.9B	24.4B	27.3B
Total assets	40.1B	40B	41B	40.8B	44.5B	43.9B	43.3B	45.1B	53.1B	57.3B
Accounts payable	17.9B	19.7B	21.5B	21.4B	23.7B	27.1B	29.9B	31.8B	34.7B	38.3B
Short-term debt	1.3B	1B	452M	10M	871M	580M	792M	434M	550M	1.9B
Total current liabilities	21.2B	22.9B	24.1B	23.6B	27.6B	30.6B	33.7B	35.6B	38.9B	43.9B
Long-term debt	9.1B	8B	7.6B	6.8B	5.4B	4.7B	3.9B	4.7B	8B	7B
Total liabilities	33.3B	33.9B	34.6B	39B	42.7B	44.6B	46.3B	48.3B	55.8B	60B
Shareholders' equity	6.8B	6.1B	6.3B	1.8B	1.8B	-706M	-3B	-3.2B	-2.6B	-2.7B
Total debt	10.4B	9B	8B	6.8B	6.2B	5.3B	4.7B	5.1B	8.5B	8.9B
Net debt	3.5B	7.3B	5.5B	4B	2.8B	598M	625M	-41M	4.7B	4B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Cash & short-term investments	3.9B	4.6B	3.7B	5.1B	2.9B	3.8B	3.3B	3.9B	4.6B	2.8B	3.9B	4.9B
Receivables	11.3B	11.8B	11.6B	12.1B	11.8B	12.4B	12.7B	13.2B	13.8B	13.7B	13.6B	13.8B
Inventory	17B	18.5B	17.3B	15B	15.6B	16.9B	16.2B	16.8B	17.6B	20.1B	18B	17.3B
Total current assets	34.7B	37.7B	35.7B	34.9B	32.9B	35.8B	34.6B	36.4B	38.5B	39.2B	38.1B	38.8B
Property, plant & equipment	—	—	—	2.5B	—	—	—	2.9B	—	—	—	3B
Goodwill & intangibles	10.9B	10.7B	13B	12.9B	12.8B	14.9B	22B	24.4B	24.2B	28B	27.4B	27.3B
Total assets	43.7B	46.6B	45.9B	45.1B	43.1B	47B	49.9B	53.1B	55.2B	58.1B	56.7B	57.3B
Accounts payable	31.5B	34.3B	32.1B	31.8B	30.4B	31.3B	32.8B	34.7B	36.9B	39B	37.8B	38.3B
Short-term debt	788M	1.2B	1.2B	434M	940M	544M	543M	550M	52M	680M	671M	1.9B
Total current liabilities	35.1B	38.3B	36.3B	35.6B	34.7B	35.2B	36.7B	38.9B	40.3B	43.3B	42B	43.9B
Long-term debt	3.9B	3.5B	4.7B	4.7B	4.2B	7.1B	7.1B	8B	9B	8.3B	8.2B	7B
Total liabilities	47.2B	50B	49.1B	48.3B	46.3B	49.9B	51.8B	55.8B	58B	60.8B	59.4B	60B
Shareholders' equity	-3.5B	-3.4B	-3.3B	-3.2B	-3.3B	-2.9B	-1.9B	-2.6B	-2.7B	-2.7B	-2.7B	-2.7B
Total debt	4.7B	4.7B	5.9B	5.1B	5.2B	7.6B	7.7B	8.5B	9B	9B	8.9B	8.9B
Net debt	824M	132M	2.1B	-41M	2.3B	3.8B	4.4B	4.7B	4.4B	6.3B	5B	4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	1.3B	259M	1.4B	-3.7B	612M	-937M	331M	853M	1.6B	1.7B
Depreciation & amortization	717M	1B	1B	913M	783M	692M	692M	710M	790M	956M
Stock-based compensation	96M	85M	82M	90M	89M	81M	96M	121M	244M	367M
Change in working capital	-774M	492M	562M	-489M	-163M	946M	1.5B	1.9B	83M	2.5B
Operating cash flow	1.6B	854M	2.9B	-4.1B	1.8B	796M	2.5B	3.5B	2.4B	5.2B
Capital expenditure	-384M	478M	435M	-373M	-400M	-356M	-469M	-499M	—	—
Investing cash flow	-405M	-5.6B	338M	493M	-378M	567M	-454M	-1.8B	-5B	-2B
Dividends paid	-577M	-581M	-577M	-569M	-573M	-559M	-525M	-499M	-494M	-491M
Share repurchases	-600M	-550M	-600M	-350M	-200M	-1B	-2B	-750M	-765M	-1.4B
Financing cash flow	3.7B	-2.3B	-2.3B	-2.2B	-1.3B	-2.5B	-3.1B	-847M	1.9B	-1.6B
Net change in cash	5B	-7B	971M	-5.8B	122M	-1.1B	-972M	827M	-712M	1.6B
Free cash flow	797M	2.4B	2.4B	1.6B	2B	2.8B	2.4B	3.3B	1.9B	4.5B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Net income	-11M	369M	261M	234M	417M	401M	508M	243M	454M	471M	380M	400M
Depreciation & amortization	172M	175M	177M	186M	182M	192M	207M	209M	233M	234M	248M	241M
Stock-based compensation	29M	28M	31M	33M	30M	30M	31M	153M	93M	87M	129M	58M
Change in working capital	747M	677M	-781M	1.3B	-1.8B	-906M	2.1B	705M	872M	-173M	909M	936M
Operating cash flow	937M	1.2B	-312M	1.8B	-1.2B	-283M	2.8B	1.5B	973M	686M	1.8B	1.7B
Capital expenditure	-91M	-113M	-104M	-191M	-90M	-99M	-123M	—	—	—	—	—
Investing cash flow	-64M	-104M	-1.8B	166M	-88M	-971M	-2.9B	-1.4B	-34M	-1.9B	-35M	-4M
Dividends paid	-131M	-124M	-122M	-122M	-128M	-122M	-124M	-120M	-129M	-122M	-120M	-120M
Share repurchases	-500M	-250M	0	0	-375M	-15M	-375M	0	-375M	-383M	-250M	-350M
Financing cash flow	-666M	-353M	1B	-859M	-540M	-538M	-503M	656M	-110M	-519M	-483M	-490M
Net change in cash	207M	792M	-1.1B	1.1B	-1.8B	-1.8B	-583M	785M	829M	-1.7B	1.3B	1.2B
Free cash flow	436M	1.1B	-134M	1.9B	-1.7B	-499M	2.8B	1.3B	865M	555M	1.7B	1.4B

Date	Ratio
Apr 23, 2001	3:2
Nov 2, 1998	3:2
Dec 17, 1996	3:2
Jul 1, 1994	5:4
Oct 1, 1991	5:4
Oct 1, 1990	5:4
Oct 2, 1989	5:4
Sep 9, 1988	11:10
Sep 9, 1987	11:10

Cardinal Health Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Cardinal Health Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history